SYMVIVO CORPORATION
Symvivo Corporation is a platform that delivers plasmid DNA, both orally and through IV administration, that enables a patientโs own cells to produce biologics. They make therapeutic developments in the fields of oral vaccines, cancer, immunology, and biologics. Symvivo Corporation is creating the next generation of vaccines by offering orally delivered, room-temperature stable medicines that can generate both systemic and mucosal immunity, as well as scalable and cost-effective manufacturing procedures.
SYMVIVO CORPORATION
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2013-01-01
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.symvivo.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
650 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt SSL By Default Global Site Tag HSTS
Similar Organizations
Alzamend Neuro
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Artiam Bio
Artiam Bio is a biotechnology focused on the development of second-generation type 1 cannabinoid receptor antagonists for the treatment.
HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
T2 Biosystems
T2 Biosystems is a biotechnology company that develops diagnostic products for rapid and accurate detection of various diseases.
Tome Biosciences
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
TruDiagnostic
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Zura Bio
Zura Bio is a clinical-stage biotechnology company that develops medicines for immune system disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pacific Economic Development Canada
Pacific Economic Development Canada investment in Grant - Symvivo Corporation
Official Site Inspections
http://www.symvivo.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Symvivo Corporation"
Symvivo Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Symvivo. Use the PitchBook Platform to explore the full profile.See details»
Symvivo Corporation Management Team | Org Chart - RocketReach
Symvivo Corporation employs 13 employees. The Symvivo Corporation management team includes Alexander Graves (Founder and CEO), Sophie Yurist-Doutsch (Associate Director, โฆSee details»
Symvivo Corporation - LinkedIn
Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life-threatening diseases. โฆSee details»
Symvivo Corporation Information - RocketReach
Symvivo Corporation is a Biotechnology Research, Business Services General, and Biotechnology company located in Burnaby, British Columbia with $6 million in revenue and 13 โฆSee details»
Symvivo Corporation - Org Chart, Teams, Culture & Jobs | The Org
View Symvivo Corporation's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Symvivo Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Symvivo Corporation of Burnaby, BC. Get the latest business insights from Dun & Bradstreet.See details»
Symvivo Corp. (Symvivo Corp.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
About Symvivo Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life โฆSee details»
Symvivo Corporation - Funding, Financials, Valuation & Investors
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.See details»
Symvivo Corporation - Crunchbase
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.See details»
Symvivo - Products, Competitors, Financials, Employees, โฆ
Symvivo is a biotechnology company in the cancer gene therapy field. The firm develops a novel bacterial based gene delivery platform technology for the treatment of solid tumors. The โฆSee details»
Alexander Graves - Symvivo Corporation | LinkedIn
I believe that nature is an incredible engine of innovation that provides us with an inexhaustible toolbox to address the challenges of our time. I am passionate about using biology to develop โฆSee details»
Symvivo - VentureRadar
"Symvivo has invented and patented a novel protein based mechanism that enables probiotic bacteria to consistently produce and deliver therapeutic plasmid DNA to colonized tissues. โฆSee details»
Symvivo - Overview, News & Similar companies | ZoomInfo.com
Jan 4, 2021 View Symvivo (www.symvivo.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Symvivo Company Profile - Office Locations, Competitors, Revenue ...
Symvivo has 5 employees at their 1 location. See insights on Symvivo including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Symvivo - CipherBio
Symvivo is a clinical-stage gene therapy company developing oral DNA vaccines for life-threatening diseases, such as COVID-19, with broader therapeutic potential for IV therapeutics โฆSee details»
Symvivo Corporation - Tech Stack, Apps, Patents & Trademarks
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.See details»
Burnaby biotech ditches needles for pills in COVID-19 fight
Aug 10, 2021 While Symvivo is working on a vaccine that delivers a gene that induces an immune response to the virus that causes COVID-19, Graves said the companyโs platform โฆSee details»
Symvivo Corporation Announces Collaboration with Merck
Jan 5, 2021 Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life-threatening โฆSee details»
Symvivo Corporation receives funding for COVID-19 Vaccine
Jul 19, 2021 About Symvivo Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of โฆSee details»